Navigation Links
Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform
Date:10/12/2011

ROCKVILLE, Md., Oct. 12, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has received a notice of allowance from the U.S. Patent and Trademark Office for patent application 12/418,170 pertaining to a "Spinal Platform and Method for Delivering a Therapeutic Agent to a Spinal Cord Target." Neuralstem is the exclusive worldwide licensee of this device from the Cleveland Clinic Foundation, where it was developed by Nicholas Boulis, MD, formerly of the Cleveland Clinic, now at Emory University. The device is currently in use in Neuralstem's ongoing Phase I safety trial of its human spinal cord stem cells (HSSCs) in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at Emory, where Dr. Boulis is the surgeon.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

"This is an important patent," said Richard Garr, Neuralstem President and CEO.  "We are encouraged by the outstanding safety profile this device demonstrated with the first 12 patients of our ongoing ALS trial, and expect that it will become the industry standard for injecting therapies into the spinal cord.  The company is the exclusive worldwide licensee, and expects to license this device to the industry and the research community."

About Neuralstem

Neuralstem's patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is conducting an ongoing FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig's disease and has been awarded orphan status designation by the FDA.

In addition to ALS, the company is also targeting major central nervous system conditions wit
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Neuralstem President and CEO to Present at the 2011 Stifel Nicolaus Annual Healthcare Conference
2. Neuralstem Awarded Department of Defense Contract for Brain Cancer Research
3. Neuralstem Reports First Quarter Financial Results and Provides Business and Clinical Update
4. Former Capital One Director and Business Leader Stanley I. Westreich Joins Neuralstems Board
5. Neuralstem, Inc. Settles Litigation Against ReNeuron, Ltd.
6. Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress
7. Neuralstem Completes $5.25 Million Financing
8. Neuralstem, Inc. Reports Third Quarter Financial Results and Provides Business Update
9. Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Neuralstem, Inc.
11. Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), a ... for the quarter ending June 30, 2015. Highlights included: ... 2015 , The final cost of the Sarnia ... million above the high end of the estimate communicated ... 10%) , The company announced commercial collaborations in ...
(Date:8/4/2015)... 4, 2015 According to ... titled, "World Cardiac Biomarker - Market Opportunities, and ... generate the revenue of $2,085.9 million by 2020, ... 2020. Cardiac Troponins (T, I) would continue to ... to high sensitivity and specificity.      ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... point-of-care (POC) diagnostic tests – today announced that Robert A. Gregg, PhD, has ... has more than 30 years of relevant experience and remarkable achievements in the ...
(Date:8/4/2015)... -- Blueprint Medicines (NASDAQ: BPMC ), a leader in ... defined diseases, today announced that Jeffrey Albers , ... the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August ... live webcast of the event will be available by ... at www.blueprintmedicines.com . An archived replay of the ...
Breaking Biology Technology:BioAmber Reports Second Quarter 2015 Financial Results 2BioAmber Reports Second Quarter 2015 Financial Results 3BioAmber Reports Second Quarter 2015 Financial Results 4BioAmber Reports Second Quarter 2015 Financial Results 5BioAmber Reports Second Quarter 2015 Financial Results 6BioAmber Reports Second Quarter 2015 Financial Results 7BioAmber Reports Second Quarter 2015 Financial Results 8BioAmber Reports Second Quarter 2015 Financial Results 9BioAmber Reports Second Quarter 2015 Financial Results 10BioAmber Reports Second Quarter 2015 Financial Results 11BioAmber Reports Second Quarter 2015 Financial Results 12Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 2Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 3Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 4Cardiac Biomarker Market is Expected to Reach $2,085.9 Million by 2020 5RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3
... May 17, 2011 Today, Molecular Devices, a leading ... and life sciences research, announced that NanoRacks, LLC has ... in NASA,s International Space Station; the M5e Reader will ... space. (Logo:   http://photos.prnewswire.com/prnh/20100406/SF82092LOGO ...
... May 16, 2011 Renowned actor and martial artist Steven ... Vladimir Putin, asking the Prime Minister,s support of the "Russia ... immortality and artificial body research. According to Seagal, "Russia 2045," ... the quality of life and make humans immortal by the ...
... 16, 2011 Children taking medication for attention deficit ... or heart-related deaths than those who were not taking ... in the journal, Pediatrics . ... of Pennsylvania and HealthCore Inc., drew data from the ...
Cached Biology Technology:Molecular Devices' SpectraMax® M5e Multi-Mode Microplate Reader Chosen to be the First Microplate Reader in Space by NanoRacks, LLC for NASA's International Space Station 2Molecular Devices' SpectraMax® M5e Multi-Mode Microplate Reader Chosen to be the First Microplate Reader in Space by NanoRacks, LLC for NASA's International Space Station 3Molecular Devices' SpectraMax® M5e Multi-Mode Microplate Reader Chosen to be the First Microplate Reader in Space by NanoRacks, LLC for NASA's International Space Station 4Steven Seagal Asks For Russian PM Vladimir Putin's Support in Immortality Research 2Pediatrics Study Finds Children Taking ADHD Medications Did Not Suffer More Serious Heart Problems or Cardiovascular-related Death 2Pediatrics Study Finds Children Taking ADHD Medications Did Not Suffer More Serious Heart Problems or Cardiovascular-related Death 3
(Date:7/27/2015)... , July 27, 2015  Synaptics Inc. ... human interface solutions, today announced that Huawei has ... touchscreen solution for its stylish smartwatch. Huawei chose ... proven reliability, low power and highly responsive human ... finger. Huawei designers also required a classic round ...
(Date:7/23/2015)... -- Aware, Inc. (NASDAQ: AWRE ), a leading supplier ... its second quarter ended June 30, 2015.  ... a decrease of 33% compared to $6.8 million in the ... of 2015 was $0.3 million, or $0.01 per diluted share, ... in the same period a year ago.  ...
(Date:7/21/2015)... GOTHENBURG, Sweden , July 21, 2015 ... sensor FPC1025. Already received as well as expected revenues in 2015 ... included in FPC,s communicated revenue guidance of approximately 2,200 MSEK for ... is a leading smartphone manufacturer in China ... selected FPC1 02 5 for Axon ...
Breaking Biology News(10 mins):Synaptics Touchscreen Solution Powers New Huawei Watch 2Synaptics Touchscreen Solution Powers New Huawei Watch 3Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
... membranes form the "skin" of most every cell in your ... in motion cannot be rendered by many experimental techniques. A ... and Technology (NIST) and University of California, Irvine, recently developed ... illuminate the important role of cholesterol within this boundary between ...
... Scientists from the United States and China have discovered ... type of flowering plant whose membership includes buttercups, apple ... find, described in this week,s Nature, reveals a remarkably ... earlier origin of the eudicots -- and perhaps flowering ...
... figures in the nuclear industry will be led by Maurie ... at NJIT. "Panelists will look at the current ... emergent implications of the disaster," Cohen said. "Speakers will discuss ... the nuclear facilities and the health implications." The public ...
Cached Biology News:Closer look at cell membrane shows cholesterol 'keeping order' 2Fossil is best look yet at an ancestor of buttercups 2Fossil is best look yet at an ancestor of buttercups 3Public forum: Japan and early lessons for the nuclear industry 2
... assay (ELISA) test kits are qualitative ... the detection of drugs and/or their metabolites ... for forensic use only. It is recommended ... a quantitative method such as GC/MS. ...
... RNase Inhibitor (patent pending) is a protein ... binds and inhibits the most common and ... 1 and T1. SUPERaseIn can be used ... be problematic. It is ideal for in ...
... Ribonuclease Inhibitor is a recombinant protein that has ... RNA in the preparation of cDNA by reverse ... vitro protein synthesis. RNA Safe Inhibitor tightly binds ... broad range of eukaryotic RNases such as RNase ...
... (Ribonuclease inhibitor) is a 50 ... inhibit RNase activity. It does ... activity. , Inhibits RNase ... template , Lacks DNA ...
Biology Products: